Search

ApoL1 N-terminal domain
Authors
Holliday, M.J., Ultsch, M., Moran, P., Fairbrother, W.J., Kirchhofer, D.
Assembly
Apolipoprotein L1
Entity
1. Apolipoprotein L1 (polymer, Thiol state: not present), 114 monomers, 13287.90 Da Detail

GSDPESSIFI EDAIKYFKEK VSTQNLLLLL TDNEAWNGFV AAAELPRNEA DELRKALDNL ARQMIMKDKN WHDKGQQYRN WFLKEFPRLK SELEDNIRRL RALADGVQKV HKGT


Formula weight
13287.9 Da
Source organism
Homo sapiens
Exptl. method
solution NMR
Data set
assigned_chemical_shifts, spectral_peak_list
Chem. Shift Complete
Sequence coverage: 95.6 %, Completeness: 85.7 %, Completeness (bb): 90.9 % Detail

Polymer type: polypeptide(L)

Total1H13C15N
All85.7 % (1200 of 1400)83.9 % (616 of 734)88.1 % (468 of 531)85.9 % (116 of 135)
Backbone90.9 % (616 of 678)89.1 % (205 of 230)92.0 % (310 of 337)91.0 % (101 of 111)
Sidechain82.3 % (684 of 831)81.5 % (411 of 504)85.1 % (258 of 303)62.5 % (15 of 24)
Aromatic85.5 % (94 of 110)85.5 % (47 of 55)84.6 % (44 of 52)100.0 % (3 of 3)
Methyl89.8 % (106 of 118)89.8 % (53 of 59)89.8 % (53 of 59)

1. entity 1

GSDPESSIFI EDAIKYFKEK VSTQNLLLLL TDNEAWNGFV AAAELPRNEA DELRKALDNL ARQMIMKDKN WHDKGQQYRN WFLKEFPRLK SELEDNIRRL RALADGVQKV HKGT

Sample

Solvent system 93% H2O/7% D2O, Pressure 1 atm, Temperature 310 K, pH 5.5, Details 0.9 mM [U-99% 13C; U-99% 15N] ApoL1 (61-172), 93% H2O/7% D2O


#NameIsotope labelingTypeConcentration
1ApoL1 (61-172)[U-99% 13C; U-99% 15N]0.9 mM

Release date
2021-01-28
Citation
Structures of the ApoL1 and ApoL2 N-terminal domains reveal a non-classical four-helix bundle motif
Ultsch, M., Holliday, M.J., Gerhardy, S., Moran, P., Scales, S.J., Gupta, N., Oltrabella, F., Chiu, C., Fairbrother, W., Eigenbrot, C., Kirchhofer, D.
Commun. Biol. (2021), 4, 916-916, PubMed 34316015 , DOI 10.1038/s42003-021-02387-5 ,
Related entities 1. Apolipoprotein L1, : 1 : 3 : 2 : 22 entities Detail
Interaction partners 1. Apolipoprotein L1, : 2 interactors Detail
Experiments performed 15 experiments Detail
Chemical shift validation 3 contents Detail
Keywords Ion channel, MEMBRANE PROTEIN, kidney disease, lipoprotein